Link to this page
Medical Subject Headings
Preferred Name | Clofazimine | |
Synonyms |
Lamprene N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine B-663 G-30,320 B 663 G 30,320 B663 G30,320 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)- |
|
Definitions |
A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619) |
|
ID |
http://purl.bioontology.org/ontology/MESH/D002991 |
|
altLabel |
Lamprene N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine B-663 G-30,320 B 663 G 30,320 B663 G30,320 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-
|
|
AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
cui |
C0733653 C0008996 C0700047 C0733652
|
|
DC |
1
|
|
definition |
A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619)
|
|
DX |
19740101
|
|
HN |
74
|
|
Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
Inverse of RB |
D959AE5USF 0
|
|
isa | ||
LT |
TRD
|
|
Machine permutation |
74
|
|
Mapped from |
http://purl.bioontology.org/ontology/MESH/C102543 http://purl.bioontology.org/ontology/MESH/C102542 http://purl.bioontology.org/ontology/MESH/C402675 http://purl.bioontology.org/ontology/MESH/C033734 http://purl.bioontology.org/ontology/MESH/C033733 http://purl.bioontology.org/ontology/MESH/C030426 http://purl.bioontology.org/ontology/MESH/C030427 http://purl.bioontology.org/ontology/MESH/C030429 http://purl.bioontology.org/ontology/MESH/C030428 |
|
MDA |
19990101
|
|
MMR |
20160528
|
|
MN |
D03.633.300.704.353
|
|
notation |
D002991
|
|
PA |
D000893 D007917
|
|
prefLabel |
Clofazimine
|
|
RR |
2030-63-9 (Clofazimine)
|
|
TERMUI |
T008647 T008649 T008648 T008650 T008651
|
|
TH |
NLM (1995) USAN (1967) FDA SRS (2014) UNK (19XX) INN (19XX) BAN (19XX)
|
|
tui |
T109 T130 T121
|
|
subClassOf |
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |